SEARCH

SEARCH BY CITATION

References

  • 1
    Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol 2010; 105:25202524.
  • 2
    Richey R, Howdle P, Shaw E, Stokes T. Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance. BMJ 2009; 338:b1684.
  • 3
    Ciclitira P, Dewar D, McLaughlin S, Sanders D. The management of adults with coeliac disease. British Society of Gastroenterology Guidelines. Available at: www.bsg.org.uk/images/stories/clinical/bsg_coeliac_10.pdf (accessed 22 January 2014).
  • 4
    Green P, Rostami K, Marsh M. Diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19:389400.
  • 5
    Donaldson M, Book L, Leiferman K, Zone J, Neuhausen S. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 2008; 42:256260.
  • 6
    Hill P, Holmes G. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008; 27:572577.
  • 7
    Vivas S, Ruiz de Morales JG, Riestra S et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009; 15:47754780.
  • 8
    Dahlbom I, Korponay-Szabo IR, Kovacs JB, Szalai Z, Maki M, Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 2010; 50:140146.
  • 9
    Zanini B, Magni A, Caselani F et al. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis 2011; 44:280285.
  • 10
    Mubarak A, Wolters V, Gmelig-Meyling F, Kate F, Houwen R. Tissue transglutaminase levels above 100 U/mL and celiac disease: a prospective study. World J Gastroenterol 2012; 18:43994403.
  • 11
    Nenna R, Tiberti C, Petrarca L et al. Anti-transglutaminase immunoreactivity and histological lesions of the duodenum in coeliac patients. Int Immunol 2013; 25:389394.
  • 12
    Husby S, Koletzko S, Korponay-Szabo IR et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54:136160.
  • 13
    Murch S, Jenkins H, Auth M et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child 2013; 98:806811.
  • 14
    Egner W, Shrimpton A, Sargur R, Patel D, Swallow K. ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres. J Pediatr Gastroenterol Nutr 2013; 55:733735.
  • 15
    Vermeersch P, Geboes K, Marien G, Hoffman I, Hiele M, Bossuyt X. Defining thresholds of antibody levels improves diagnosis of celiac disease. Clin Gastroenterol Hepatol 2013; 11:398403.
  • 16
    Giersiepen K, Lelgemann M, Stuhldreher N et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 2012; 54:229241.
  • 17
    Klapp G, Masip E, Bolonio M et al. Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population. J Pediatr Gastroenterol Nutr 2013; 56:251256.
  • 18
    Ravelli A, Villanacci V. Tricks of the trade: how to avoid histological pitfalls in celiac disease. Pathol Res Pract 2012; 208:197202.
  • 19
    White G. Basics of estimating measurement uncertainty. Clin Biochem Rev 2008; 29:S53.